sabinene has been researched along with Cardiac Conduction Defect in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, JL; Alvarez-Collazo, J; López-Requena, A; Talavera, K | 1 |
| Alvarez, JL; Alvarez-Collazo, J; Galán, L; López-Requena, A; Talavera, A; Talavera, K | 1 |
2 other study(ies) available for sabinene and Cardiac Conduction Defect
| Article | Year |
|---|---|
The Citrus Flavonoid Hesperetin Has an Inadequate Anti-Arrhythmic Profile in the ΔKPQ Na
Topics: Anti-Arrhythmia Agents; Cardiac Conduction System Disease; Cells, Cultured; Citrus; Dose-Response Relationship, Drug; HEK293 Cells; Hesperidin; Humans; Long QT Syndrome; Mutation; NAV1.5 Voltage-Gated Sodium Channel | 2020 |
The citrus flavanone hesperetin preferentially inhibits slow-inactivating currents of a long QT syndrome type 3 syndrome Na
Topics: Animals; Aorta, Abdominal; Cardiac Conduction System Disease; Cardiotonic Agents; Citrus; Heart; HEK293 Cells; Hesperidin; Humans; Long QT Syndrome; Male; Models, Molecular; Mutation; NAV1.5 Voltage-Gated Sodium Channel; Rats, Wistar; Vasodilator Agents | 2019 |